Eur Rev Med Pharmacol Sci 2008; 12 (2): 127-130

Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren’s syndrome treated with infliximab: Case report

A. Migliore1, A. Signore2,4, A. Capuano1, E. Bizzi1, U. Massafra1, F. Vacca1, V. Todino2, M. Chianelli3,4

1 UOS of Rheumatology, Fatebenefratelli, S. Pietro Hospital, Rome (Italy) 2 Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, (The Netherlands) 3 Nuclear Medicine Department, Regina Apostolorum Hospital, Albano, Rome (Italy) 4 Nuclear Medicine Department, S. Andrea Hospital, 2nd Medical School, University La Sapienza, Rome (Italy)


We report the case of a 59 years old woman affected by lung and joint sarcoidosis, secondary Sjogren’s syndrome refractory to common disease-modifying antirheumatic drugs (DMARDs) that regressed with infliximab and methotrexate. 99mTc-HYNIC- TOC scintigraphy was useful in diagnosis, choice of treatment and follow-up.

Corresponding Author: Alberto Migliore, MD; e-mail: albertomigliore@terra.es

Free PDF Download

To cite this article

A. Migliore1, A. Signore2,4, A. Capuano1, E. Bizzi1, U. Massafra1, F. Vacca1, V. Todino2, M. Chianelli3,4
Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren’s syndrome treated with infliximab: Case report

Eur Rev Med Pharmacol Sci
Year: 2008
Vol. 12 - N. 2
Pages: 127-130